The move comes as schools reopen after the holiday break.
January 3, 2022, 3:03 PM
• 1 min read
The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds.
The moves comes as schools reopen after the holiday break.
In a release, the FDA said it has amended the emergency use authorization for the Pfizer vaccine to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.
This is a developing story. Please check back for updates.
Pupils sitting behind partition boards made of plexiglass attend a class at a primary school, during the coronavirus disease (COVID-19) outbreak, in Den Bosch, Netherlands, May 8, 2020. REUTERS/Piroschka van de Wouw January 3, 2022 THE HAGUE (Reuters) – The Netherlands, under a strict COVID-19 lockdown for the past two […]
